Skip to content

Clinical trials

Down Syndrome trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Down Syndrome Phase: Not applicable Country / region: United States Clear all

79 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20063
20071
20104
20132
20142
20155
20162
20173
201810
20195
20204
20219
20223
20236
20245
20259
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50
Recruiting15
Terminated5
Unknown status3
Active, not recruiting3
Enrolling by invitation2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Kansas Medical Center8
University of Michigan5
Boston Children's Hospital3
Children's Hospital of Philadelphia3
Oregon Health and Science University3
University of Nevada, Las Vegas3
University of Wisconsin, Madison3
Wake Forest University Health Sciences3
Children's Hospital Medical Center, Cincinnati2
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Down Syndrome79
Sleep Apnea, Obstructive11
Intellectual Disability8
Cerebral Palsy7
Alzheimer Disease5
Autism Spectrum Disorder4
Autistic Disorder4
Developmental Disabilities4
Obesity4
Weight Loss3

Trials

Showing 1 to 25 of 79. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.